Teva news

We improve the quality and extend interaction with healthcare professionals, due to this we launch a webinar portal.
On March 4, the very first and unique online webinar was held within the "Glatiramer acetate 40 mg" symposium: Today principles and optimization of therapy for patients with remittent multiple sclerosis.

This transaction strengthens Teva's strategy, facilitates an accelerated transition to a new business model and opens up new opportunities for the company in the production of generics and specialty. The company provides medicinal products to 250 million people around the world every day.